Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed adds HHS health policy adviser

Executive Summary

Ann-Marie Lynch joins AdvaMed as exec VP-payment and healthcare delivery, bringing more than 15 years of health care policy experience to the post, the device trade group reports. Lynch served most recently as principal deputy assistant secretary in the HHS Office of the Assistant Secretary for Planning & Evaluation. She will join AdvaMed Oct. 24, succeeding exec VP Carol Kelly, who left the association in June to become director of CMS' new Office of Policy (1"The Pink Sheet" May 30, 2005, In Brief)....

You may also be interested in...



CMS Office of Policy

AdvaMed Exec VP Carol Kelly will join the Centers for Medicare & Medicaid Services to head a newly formed Office of Policy June 13. Kelly will lead a staff drawn from CMS' current Planning & Policy Analysis Group within the Office of Research, Development & Information. ORDI's Mary Ellen Stahlman will be assistant director of the office. Kelly joined AdvaMed in 1999; she previously worked at CMS (formerly known as HCFA) from 1982-1986...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel